Here we reviewed the use of adalimumab for treatment of neurosarcoidosis, and the risk of adverse complications in patients at our center.
No takes yet. Share an insight, caveat, or question.
Sugita et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: